Terms: = Breast cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Staging
12 results:
1. Naples score: a novel prognostic biomarker for breast cancer patients undergoing neoadjuvant chemotherapy.
Xiu Y; Jiang C; Huang Q; Yu X; Qiao K; Wu D; Yang X; Zhang S; Lu X; Huang Y
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16097-16110. PubMed ID: 37698677
[TBL] [Abstract] [Full Text] [Related]
2. The aldh2, IGSF9, and PRDM16 Proteins as Predictive Biomarkers for Prognosis in breast cancer.
Han Y; Fu Y; Shi Q; Liu H; Sun H; Niu C; Fu L
Clin Breast Cancer; 2023 Apr; 23(3):e140-e150. PubMed ID: 36639264
[TBL] [Abstract] [Full Text] [Related]
3. Concurrent breast Carcinoma and Follicular Lymphoma: A Case Series.
Saleem T; Mi K; Pathak R; Yari K; Lu K
Am J Case Rep; 2021 Nov; 22():e931772. PubMed ID: 34764233
[TBL] [Abstract] [Full Text] [Related]
4. Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.
Wang Y; Qiao L; Yang J; Li X; Duan Y; Liu J; Chen S; Li H; Liu D; Fang T; Ma J; Li X; Ye F; Wan J; Wei J; Xu Q; Guo E; Jin P; Wu M; Zhang L; Xia Y; Wu Y; Shao J; Feng Y; Zhang Q; Yang Z; Chen G; Zhang Q; Li X; Wang S; Hu J; Wang X; Tan MP; Takabe K; Kong B; Yang Q; Ma D; Gao Q
Cancer Commun (Lond); 2021 Dec; 41(12):1373-1386. PubMed ID: 34738326
[TBL] [Abstract] [Full Text] [Related]
5. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
[TBL] [Abstract] [Full Text] [Related]
6. Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.
Lerebours F; Pulido M; Fourme E; Debled M; Becette V; Bonnefoi H; Rivera S; MacGrogan G; Mouret-Reynier MA; de Lara CT; Pierga JY; Breton-Callu C; Venat-Bouvet L; Mathoulin-Pélissier S; de la Motte Rouge T; Dalenc F; Sigal B; Bachelot T; Lemonnier J; Quenel-Tueux N
Br J Cancer; 2020 Mar; 122(6):759-765. PubMed ID: 32001832
[TBL] [Abstract] [Full Text] [Related]
7. cancer Yield of Incidental breast Lesions Detected on Chest Computed Tomography.
Healey TT; Agarwal S; Patel R; Ratanaprasatporn L; Ratanaprasatporn L; Lourenco AP
J Comput Assist Tomogr; 2018; 42(3):453-456. PubMed ID: 29016373
[TBL] [Abstract] [Full Text] [Related]
8. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
Höckel M; Hentschel B; Horn LC
Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
[TBL] [Abstract] [Full Text] [Related]
9. The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients.
Barak F; Milgrom R; Laitman Y; Gemer O; Rabinovich A; Piura B; Anteby E; Baruch GB; Korach J; Friedman E
Gynecol Oncol; 2010 Dec; 119(3):511-5. PubMed ID: 20850175
[TBL] [Abstract] [Full Text] [Related]
10. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast.
Boughey JC; Middleton LP; Harker L; Garrett B; Fornage B; Hunt KK; Babiera GV; Dempsey P; Bedrosian I
Am J Surg; 2007 Oct; 194(4):450-5. PubMed ID: 17826054
[TBL] [Abstract] [Full Text] [Related]
11. Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
Dehqanzada ZA; Storrer CE; Hueman MT; Foley RJ; Harris KA; Jama YH; Shriver CD; Ponniah S; Peoples GE
Oncol Rep; 2007 Mar; 17(3):687-94. PubMed ID: 17273752
[TBL] [Abstract] [Full Text] [Related]
12. Results of treating 1,178 patients with breast cancer by radical mastectomy and postoperative irradiation where metastases to axillary lymph nodes occurred.
Ariel IM
J Surg Oncol; 1979; 12(2):137-53. PubMed ID: 491682
[TBL] [Abstract] [Full Text] [Related]
